3,566 Shares in Colgate-Palmolive (NYSE:CL) Bought by Fidelis Capital Partners LLC

Fidelis Capital Partners LLC acquired a new position in Colgate-Palmolive (NYSE:CL) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,566 shares of the company’s stock, valued at approximately $284,000.

Several other institutional investors also recently modified their holdings of CL. Dimensional Fund Advisors LP grew its stake in shares of Colgate-Palmolive by 4.0% in the first quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after purchasing an additional 94,837 shares during the last quarter. Covestor Ltd grew its stake in shares of Colgate-Palmolive by 71.9% in the first quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after purchasing an additional 1,025 shares during the last quarter. Mackenzie Financial Corp grew its stake in shares of Colgate-Palmolive by 8.5% in the first quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after purchasing an additional 146,936 shares during the last quarter. First Western Trust Bank acquired a new position in Colgate-Palmolive in the first quarter valued at $569,000. Finally, Wsfs Capital Management LLC acquired a new position in Colgate-Palmolive in the first quarter valued at $288,000. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now directly owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, insider Jennifer Daniels sold 61,633 shares of the firm’s stock in a transaction that occurred on Thursday, February 1st. The shares were sold at an average price of $83.93, for a total value of $5,172,857.69. Following the completion of the transaction, the insider now directly owns 57,948 shares of the company’s stock, valued at approximately $4,863,575.64. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Noel R. Wallace sold 50,000 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the completion of the sale, the chief executive officer now owns 274,179 shares in the company, valued at $22,797,983.85. The disclosure for this sale can be found here. In the last ninety days, insiders sold 232,371 shares of company stock valued at $19,505,099. Company insiders own 0.34% of the company’s stock.

Colgate-Palmolive Stock Up 1.1 %

Colgate-Palmolive stock opened at $87.13 on Friday. Colgate-Palmolive has a twelve month low of $67.62 and a twelve month high of $90.37. The firm has a 50 day moving average price of $87.10 and a 200-day moving average price of $80.78. The company has a market capitalization of $71.62 billion, a P/E ratio of 31.34, a P/E/G ratio of 3.26 and a beta of 0.42. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, beating analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The firm had revenue of $4.95 billion during the quarter, compared to the consensus estimate of $4.89 billion. During the same period in the prior year, the firm earned $0.77 EPS. The company’s revenue was up 6.9% compared to the same quarter last year. As a group, equities analysts predict that Colgate-Palmolive will post 3.5 EPS for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be issued a $0.50 dividend. The ex-dividend date of this dividend is Friday, April 19th. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a yield of 2.30%. Colgate-Palmolive’s dividend payout ratio (DPR) is 69.06%.

Analyst Upgrades and Downgrades

CL has been the topic of several recent analyst reports. UBS Group boosted their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a report on Monday, January 29th. Morgan Stanley upped their price objective on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a report on Monday, January 29th. Evercore ISI upped their price objective on shares of Colgate-Palmolive from $90.00 to $96.00 and gave the company an “outperform” rating in a report on Monday, April 8th. Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a report on Monday, January 29th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Three investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and a consensus price target of $89.50.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.